Business Context and Reporting Period
Company: Inmune Bio, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 31, 2020
Reporting Period Context: The filing announces upcoming events related to the second quarter ended June 30, 2020, rather than providing the financial results for that period directly.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This 8-K serves as a notification of upcoming communications regarding these metrics.
Material Changes
No material financial changes or operational updates are detailed in this specific filing. The document solely reports the scheduling of investor communications.
Guidance, Outlook, and Management Commentary
- Q2 Earnings Call: The Company announced a conference call scheduled for August 5, 2020, to discuss results for the second quarter ended June 30, 2020.
- Conference Presentation: The Company announced it will present a corporate overview at the BTIG Virtual Biotechnology Conference on August 10-11, 2020.
- Exhibits: Press releases regarding these events are attached as Exhibit 99.1 and Exhibit 99.2.
Investor Verification Checklist
- Verify the actual Q2 2020 financial results released on or after August 5, 2020.
- Review the content of the press releases attached as Exhibit 99.1 and 99.2 for specific details on the conference call and presentation.
- Confirm the Company's status as an emerging growth company (indicated as yes in the filing).